Table 2. Prevalence of TET2 mutation in myeloproliferative neoplasms [10].
TET2: Ten-Eleven Translocation-2
| Myeloproliferative neoplasms | TET2 mutation prevalence |
| Polycythemia vera | 16.8% |
| Essential thrombocythemia | 9.8% |
| Myelofibrosis | 15.7% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.